Literature DB >> 6228743

The role of IgA and IgG immune complexes in IgA nephropathy.

J Egido, J Sancho, F Rivera, L Hernando.   

Abstract

The presence of circulating immune complexes in 54 patients with IgA nephropathy has been studied by two different techniques. 64% of the patients had IgG immune complexes and 37% had IgA immune complexes, both determined with the Raji cell assay, and 48% of patients had IgA immune complexes with the anti-IgA inhibition binding assay (anti-IgA Inh BA). In sequential sera from individual patients, immune complexes remained persistently positive or negative in more than 50% of the cases being intermittently in the rest. The immune complexes detected by the Raji cell assay were mostly of 7-13S in size, while those detected by anti-IgA Inh BA were bigger. There was a good correlation between the serum levels of polymeric IgA and the presence of IgA complexes (Raji cell assay). A certain correlation (p less than 0.05) was found between these IgA immune complexes and the clinical activity assessed by the hematuria. A similar correlation (p less than 0.05) was found with specific polymeric IgA immune complexes studied by a method recently described. No relationship was observed between the presence of any HLA antigens and the existence of circulating immune complexes. These results support the contention that IgA immune complexes, especially those composed of polymeric IgA, may have a role in the pathogenesis of IgA nephropathy. Moreover, the high serum levels of polymeric IgA observed in these patients could contribute to the slow clearance and long persistence in the circulation of IgA immune complexes with their subsequent deposition at the glomerular mesangium.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6228743     DOI: 10.1159/000183115

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  12 in total

1.  Oligoclonally expanding gammadelta T lymphocytes induce IgA switching in IgA nephropathy.

Authors:  S Toyabe; W Harada; M Uchiyama
Journal:  Clin Exp Immunol       Date:  2001-04       Impact factor: 4.330

2.  Detection and characterization of circulating and glomerular immune complexes in experimental IgA nephropathy.

Authors:  J González-Cabrero; J Egido; A Barat; E González
Journal:  Immunology       Date:  1990-07       Impact factor: 7.397

3.  Presence of shared idiotypes in serum and immune complexes in patients with IgA nephropathy.

Authors:  J González-Cabrero; J Egido; J Sancho; F Moldenhauer
Journal:  Clin Exp Immunol       Date:  1987-06       Impact factor: 4.330

4.  Increased serum levels of IgA1-IgG immune complexes and anti-F(ab')2 antibodies in patients with primary IgA nephropathy.

Authors:  F P Schena; A Pastore; N Ludovico; R A Sinico; S Benuzzi; V Montinaro
Journal:  Clin Exp Immunol       Date:  1989-07       Impact factor: 4.330

Review 5.  IgA nephropathy.

Authors:  M C Béné; G Faure
Journal:  Springer Semin Immunopathol       Date:  1987

6.  Hypercomplementemia in adult patients with IgA nephropathy.

Authors:  Kisara Onda; Hiroyuki Ohi; Mariko Tamano; Isao Ohsawa; Michiro Wakabayashi; Satoshi Horikoshi; Teizo Fujita; Yasuhiko Tomino
Journal:  J Clin Lab Anal       Date:  2007       Impact factor: 2.352

7.  Effect of fatty acid anilides on immune responses of Swiss mice.

Authors:  R Blasco; V Ruiz-Gutierrez
Journal:  Clin Exp Immunol       Date:  1992-07       Impact factor: 4.330

8.  Effect of cyclosporine A on circulating immune complexes in IgA nephropathy.

Authors:  K N Lai; C W Lam; I K Cheng; J S Tam; F M Lai
Journal:  Int Urol Nephrol       Date:  1991       Impact factor: 2.370

9.  IgA-associated renal diseases: antibodies to environmental antigens in sera and deposition of immunoglobulins and antigens in glomeruli.

Authors:  M W Russell; J Mestecky; B A Julian; J H Galla
Journal:  J Clin Immunol       Date:  1986-01       Impact factor: 8.317

10.  Response of circulating immune complexes to food challenge in relapsing IgA nephropathy.

Authors:  J Feehally; T J Beattie; P E Brenchley; B M Coupes; N P Mallick; R J Postlethwaite
Journal:  Pediatr Nephrol       Date:  1987-10       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.